JP2021518152A5 - - Google Patents

Info

Publication number
JP2021518152A5
JP2021518152A5 JP2020551267A JP2020551267A JP2021518152A5 JP 2021518152 A5 JP2021518152 A5 JP 2021518152A5 JP 2020551267 A JP2020551267 A JP 2020551267A JP 2020551267 A JP2020551267 A JP 2020551267A JP 2021518152 A5 JP2021518152 A5 JP 2021518152A5
Authority
JP
Japan
Prior art keywords
polynucleotide
recombinant virus
gene
ehv
cell line
Prior art date
Application number
JP2020551267A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019179345A5 (https=
JP7387623B2 (ja
JP2021518152A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2019/078057 external-priority patent/WO2019179345A1/en
Publication of JP2021518152A publication Critical patent/JP2021518152A/ja
Publication of JPWO2019179345A5 publication Critical patent/JPWO2019179345A5/ja
Publication of JP2021518152A5 publication Critical patent/JP2021518152A5/ja
Application granted granted Critical
Publication of JP7387623B2 publication Critical patent/JP7387623B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020551267A 2018-03-19 2019-03-14 標的タンパク質を安定して発現できる組換えウイルス Active JP7387623B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2018079410 2018-03-19
CNPCT/CN2018/079410 2018-03-19
PCT/CN2019/078057 WO2019179345A1 (en) 2018-03-19 2019-03-14 Recombinant virus capable of stably expressing target proteins

Publications (4)

Publication Number Publication Date
JP2021518152A JP2021518152A (ja) 2021-08-02
JPWO2019179345A5 JPWO2019179345A5 (https=) 2022-03-17
JP2021518152A5 true JP2021518152A5 (https=) 2022-03-17
JP7387623B2 JP7387623B2 (ja) 2023-11-28

Family

ID=67988104

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020551267A Active JP7387623B2 (ja) 2018-03-19 2019-03-14 標的タンパク質を安定して発現できる組換えウイルス

Country Status (9)

Country Link
US (1) US11904010B2 (https=)
EP (1) EP3768831A4 (https=)
JP (1) JP7387623B2 (https=)
KR (1) KR102785418B1 (https=)
CN (1) CN111902535B (https=)
AU (1) AU2019237413C1 (https=)
CA (1) CA3094416A1 (https=)
MX (1) MX2020009720A (https=)
WO (1) WO2019179345A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3094416A1 (en) * 2018-03-19 2019-09-26 Boehringer Ingelheim Vetmedica (China) Co., Ltd. Recombinant virus capable of stably expressing target proteins
CA3162622A1 (en) * 2019-11-25 2021-06-03 Baylor College Of Medicine Selective expansion of gene-targeted cells
CN112430625B (zh) * 2020-11-23 2022-08-05 武汉枢密脑科学技术有限公司 含有变异猪伪狂犬病病毒gD蛋白基因的重组腺相关病毒转移载体、病毒及其制备和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4110962A1 (de) * 1991-04-05 1992-10-08 Bayer Ag Equine herpesviren (ehv), die fremd-dna enthalten, verfahren zu ihrer herstellung und ihre verwendung in impfstoffen
MX9206981A (es) * 1991-12-06 1994-08-31 Whitehead Biomedical Inst Vacunas de recombinantes y metodo para producirlas.
GB9927353D0 (en) * 1999-11-19 2000-01-19 Cantab Pharma Res Virus preparation and use
EP2468768A3 (en) * 2005-07-21 2012-10-31 Abbott Laboratories Multiple gene expression including sorf contructs and methods with polyproteins, pro-proteins, and proteolysis
BRPI0618441B8 (pt) * 2005-11-10 2021-07-27 Genvec Inc vetor adenoviral
CN101444622A (zh) * 2008-06-06 2009-06-03 中国人民解放军军事医学科学院军事兽医研究所 以猪伪狂犬病病毒为载体的日本血吸虫基因重组活疫苗生产工艺及制品
RU2546247C2 (ru) 2013-06-06 2015-04-10 Автономная некоммерческая организация "Научно-исследовательский институт диагностики и профилактики болезней человека и животных" (АНО "НИИ ДПБ") Вакцина против чумы, аденовирусных инфекций, парвовирусного и коронавирусного энтеритов, лептоспироза и бешенства собак
MA42640B1 (fr) * 2015-11-23 2021-06-30 Merial Inc Protéines de fusion de dmdv et e2 et leurs utilisations
CN107723281B (zh) 2017-09-09 2021-02-12 中国农业科学院哈尔滨兽医研究所 表达猪圆环病毒2型Cap蛋白的重组猪瘟兔化弱毒疫苗株及其应用
EA202092164A1 (ru) * 2018-03-19 2021-02-10 Бёрингер Ингельхайм Ветмедика Гмбх Новый ehv с инактивированным ul18 и/или ul8
CA3094416A1 (en) * 2018-03-19 2019-09-26 Boehringer Ingelheim Vetmedica (China) Co., Ltd. Recombinant virus capable of stably expressing target proteins

Similar Documents

Publication Publication Date Title
Collisson et al. Cytotoxic T lymphocytes are critical in the control of infectious bronchitis virus in poultry
CN113666990B (zh) 一种诱导广谱抗冠状病毒的t细胞疫苗免疫原及其应用
US10905756B2 (en) Bivalent swine influenza virus vaccine
JP5508252B2 (ja) 鳥インフルエンザ遺伝子を含有する組み換え七面鳥ヘルペスウイルス
CN107073100B (zh) Fmdv重组疫苗及其用途
Robinson et al. Global foot‐and‐mouth disease research update and gap analysis: 3‐Vaccines
Zhu SARS immunity and vaccination
JP4365023B2 (ja) 組換えブタ・アデノウイルス・ベクター
JP6951429B2 (ja) 新規のブタインフルエンザワクチン
JP2020500012A (ja) ブタパルボウイルスに対するワクチン
JP7587612B2 (ja) 改変ｐｅｄｖスパイクタンパク質
KR20190021334A (ko) 감염성 기관지염 바이러스에 대한 백신
JP2022527627A (ja) ３型ブタサーコウイルス（ｐｃｖ３）ワクチン、ならびにその作製および使用
US20210338807A1 (en) Covid19 vaccines and related methods
WO2023023940A1 (zh) 一种诱导广谱抗冠状病毒的t细胞疫苗免疫原及其应用
JP2021518152A5 (https=)
Tang et al. A recombinant adenovirus expressing the E protein of duck Tembusu virus induces protective immunity in duck
JP7387623B2 (ja) 標的タンパク質を安定して発現できる組換えウイルス
JP2003230396A (ja) ｇｐ３５０／２２０非スプライシング変異体
JP2019520338A (ja) ウマインフルエンザウイルス弱毒生ワクチン
JP2024512103A (ja) ワクチンプラットフォームとしての高弱毒化複製可能組換えポックスウイルスおよびその利用方法
WO2025044919A2 (en) New dev vectors
JPWO2019179345A5 (https=)
Ren et al. Construction of a recombinant BHV-1 expressing the VP1 gene of foot and mouth disease virus and its immunogenicity in a rabbit model
Zhang et al. Baculovirus-expressed FAdV-4 penton base protein protects chicken against hepatitis-hydropericardium syndrome